Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 02, 2026 07:00 ET | Source: Herantis Pharma plc

Herantis reports positive FDA feedback and finalizes Phase 2a study design for HER-096

FDA considered the planned HER-096 Phase 2a study design appropriateStudy design finalized; approximately 100 patients to be enrolledMore than 50% of Phase 2 funding secured or identified Espoo,...
June 02, 2026 05:57 ET | Source: Herantis Pharma plc

Herantis reports positive FDA feedback and finalizes Phase 2a study design for HER-096

FDA considered the planned HER-096 Phase 2a study design appropriateStudy design finalized; approximately 100 patients to be enrolledMore than 50% of Phase 2 funding secured or identified Espoo,...
May 19, 2026 07:00 ET | Source: Herantis Pharma plc

Herantis Pharma partners with Indivi to enable detection of early treatment effects in upcoming HER-096 Phase 2 trial in Parkinson’s disease

Herantis Pharma Plc – Press release Indivi’s digital biomarker platform is designed to enable earlier and more sensitive detection of treatment-related changes Improved sensitivity and reduced...
February 19, 2026 10:35 ET | Source: Herantis Pharma plc

Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096

Funding to support the execution of a Phase 2 proof-of-concept trial of HER-096 in Parkinson’s disease, following completion of study preparations Espoo, Finland, 19 February 2026: Herantis Pharma...